Roberto Luksch
Impact in
Papers in
- Neurology 71
- Neuroblastoma Research and Treatments 71
-
- Sarcoma Diagnosis and Treatment 45
- Co-authors
- Maura Massimino (74 shared papers)Andrea Ferrari (67 shared papers)Michela Casanova (66 shared papers)Marta Podda (62 shared papers)Monica Terenziani (59 shared papers)Filippo Spreafico (62 shared papers)Alberto Garaventa (26 shared papers)Franca Fossati‐Bellani (30 shared papers)
- Journals
- Journal of Clinical Oncology (33 papers)Pediatric Blood & Cancer (18 papers)Cancer (7 papers)European Journal of Cancer (6 papers)Journal of Pediatric Hematology/Oncology (6 papers)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Roberto Luksch
180 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 124
- Neurology 1.5k
- Genetics 431
- Pulmonary and Respiratory Medicine 1.1k
- Cancer Research 511
- Hematology 334
Countries citing papers authored by Roberto Luksch
This map shows the geographic impact of Roberto Luksch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Luksch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Luksch more than expected).
Fields of papers citing papers by Roberto Luksch
This network shows the impact of papers produced by Roberto Luksch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Luksch. The network helps show where Roberto Luksch may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Luksch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 190 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma. | 2003 | 156 |
| 2 | 2002 | 130 | |
| 3 | 2009 | 129 | |
| 4 | 2009 | 105 | |
| 5 | 1991 | 102 | |
| 6 | 1990 | 100 | |
| 7 | 2008 | 100 | |
| 8 | 2008 | 95 | |
| 9 | 2016 | 95 | |
| 10 | 2014 | 92 | |
| 11 | 2010 | 89 | |
| 12 | 2010 | 89 | |
| 13 | 2005 | 88 | |
| 14 | 2012 | 83 | |
| 15 | 2020 | 71 | |
| 16 | 2003 | 69 | |
| 17 | 1993 | 68 | |
| 18 | 2012 | 68 | |
| 19 | 2009 | 67 | |
| 20 | 2006 | 64 |
About Roberto Luksch
Roberto Luksch is a scholar working on Neurology, Pulmonary and Respiratory Medicine, Molecular Biology, Pediatrics, Perinatology and Child Health and Oncology, having authored 190 papers that have together received 4.5k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (71 papers), Sarcoma Diagnosis and Treatment (45 papers), Childhood Cancer Survivors' Quality of Life (23 papers), Cancer, Hypoxia, and Metabolism (16 papers), Cancer therapeutics and mechanisms (13 papers), Renal and related cancers (9 papers), Lymphoma Diagnosis and Treatment (8 papers) and Lung Cancer Research Studies (7 papers). The work is most often cited by research in Neurology (1.5k citations), Genetics (431 citations), Pulmonary and Respiratory Medicine (1.1k citations), Cancer Research (511 citations) and Hematology (334 citations). Roberto Luksch has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Maura Massimino, Andrea Ferrari, Michela Casanova, Marta Podda, Monica Terenziani, Filippo Spreafico, Alberto Garaventa, Franca Fossati‐Bellani, Paola Collini and Graziella Cefalo. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Blood & Cancer, Cancer, European Journal of Cancer and Journal of Pediatric Hematology/Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.